amobarbital has been researched along with Obesity in 8 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FEINBLATT, HM | 1 |
| FEINBLATT, TM | 1 |
| FERGUSON, EA | 1 |
| NECHELES, H | 1 |
| SORTER, H | 1 |
| FAZEKAS, JF | 1 |
| EHRMANTRAUT, WR | 1 |
| KLEH, J | 1 |
| GELVIN, EP | 1 |
| KENIGSBERG, S | 1 |
| BOYD, LJ | 1 |
| TURNER, RW | 1 |
| MILLIGAN, J | 1 |
| ORT, F | 1 |
| Hadler, AJ | 1 |
| Bailly, PJ | 1 |
| Harant, Y | 1 |
| Lanfronchi, J | 1 |
1 trial available for amobarbital and Obesity
| Article | Year |
|---|---|
Phenmetrazine vs. phenmetrazine with amobarbital for weight reduction: a double-blind study.
Topics: Adult; Aged; Amobarbital; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Obesity; Phen | 1969 |
7 other studies available for amobarbital and Obesity
| Article | Year |
|---|---|
Treatment of obesity with d-amphetamine hydrochloride and amobarbital.
Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Central Nervous System Stimulants; Dextroamphe | 1956 |
Balanced amphetamine and sedative combination in the treatment of obesity.
Topics: Amobarbital; Amphetamine; Amphetamines; Barbiturates; Hypnotics and Sedatives; Obesity; Phenobarbita | 1957 |
A study of the effectiveness of certain anorexigenic agents.
Topics: Amobarbital; Amphetamine; Amphetamines; Obesity; Sympathomimetics | 1958 |
Results of addition of liothyronine to a weight-reducing regimen.
Topics: Amobarbital; Amphetamine; Amphetamines; Humans; Obesity; Triiodothyronine | 1959 |
HYPERTENSION AND ITS COMPLICATIONS. 2.
Topics: Amobarbital; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Cold Temperature | 1964 |
ADJUVANT TREATMENT OF OBESITY WITH AN ANORECTIC-CALORIGENIC AGENT.
Topics: Adjuvants, Pharmaceutic; Amobarbital; Appetite Depressants; Energy Metabolism; Methamphetamine; Obes | 1963 |
[Value of a neuroendocrine-acting drug in the treatment of female obesity].
Topics: Adult; Amobarbital; Female; Humans; Hydroxypropiophenone; Middle Aged; Obesity | 1965 |